Drospirenone and estradiol

( ARTG ) This medicine is indicated for use as: an oral contraceptive. treatment of moderate acne vulgaris in women who seek oral contraception. treatment of symptoms of premenstrual d​‍​​​​​‍​‍‍‍‍​‍‍ysphoric disorder (PMDD) in women who have chosen oral contraceptives as their method of birth control. The efficacy of drospirenone 3 mg /ethinylestradiol 20 µg for PMDD was not assessed beyond 3 cycles. Drospirenone 3 mg /ethinylestradiol 20 µg has not been evaluated for treatment of PMS (premenstrual syndrome), see section 5.1 Pharmacodynamic Properties - Clinical trials.